Cargando…

Strategies for Using Antigen Rapid Diagnostic Tests to Reduce Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Low- and Middle-Income Countries: A Mathematical Modelling Study Applied to Zambia

BACKGROUND: Increasing the availability of antigen rapid diagnostic tests (Ag-RDTs) in low- and middle-income countries (LMICs) is key to alleviating global SARS-CoV-2 testing inequity (median testing rate in December 2021–March 2022 when the Omicron variant was spreading in multiple countries: high...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Alvin X, Girdwood, Sarah J, Khan, Shaukat, Sacks, Jilian A, Toporowski, Amy, Huq, Naushin, Hannay, Emma, Russell, Colin A, Nichols, Brooke E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619661/
https://www.ncbi.nlm.nih.gov/pubmed/36208211
http://dx.doi.org/10.1093/cid/ciac814
_version_ 1784821277457907712
author Han, Alvin X
Girdwood, Sarah J
Khan, Shaukat
Sacks, Jilian A
Toporowski, Amy
Huq, Naushin
Hannay, Emma
Russell, Colin A
Nichols, Brooke E
author_facet Han, Alvin X
Girdwood, Sarah J
Khan, Shaukat
Sacks, Jilian A
Toporowski, Amy
Huq, Naushin
Hannay, Emma
Russell, Colin A
Nichols, Brooke E
author_sort Han, Alvin X
collection PubMed
description BACKGROUND: Increasing the availability of antigen rapid diagnostic tests (Ag-RDTs) in low- and middle-income countries (LMICs) is key to alleviating global SARS-CoV-2 testing inequity (median testing rate in December 2021–March 2022 when the Omicron variant was spreading in multiple countries: high-income countries = 600 tests/100 000 people/day; LMICs = 14 tests/100 000 people/day). However, target testing levels and effectiveness of asymptomatic community screening to impact SARS-CoV-2 transmission in LMICs are unclear. METHODS: We used Propelling Action for Testing and Treating (PATAT), an LMIC-focused agent-based model to simulate coronavirus disease 2019 (COVID-19) epidemics, varying the amount of Ag-RDTs available for symptomatic testing at healthcare facilities and asymptomatic community testing in different social settings. We assumed that testing was a function of access to healthcare facilities and availability of Ag-RDTs. We explicitly modelled symptomatic testing demand from individuals without SARS-CoV-2 and measured impact based on the number of infections averted due to test-and-isolate. RESULTS: Testing symptomatic individuals yields greater benefits than any asymptomatic community testing strategy until most symptomatic individuals who sought testing have been tested. Meeting symptomatic testing demand likely requires at least 200–400 tests/100 000 people/day, on average, as symptomatic testing demand is highly influenced by individuals without SARS-CoV-2. After symptomatic testing demand is satisfied, excess tests to proactively screen for asymptomatic infections among household members yield the largest additional infections averted. CONCLUSIONS: Testing strategies aimed at reducing transmission should prioritize symptomatic testing and incentivizing test-positive individuals to adhere to isolation to maximize effectiveness.
format Online
Article
Text
id pubmed-9619661
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-96196612022-11-04 Strategies for Using Antigen Rapid Diagnostic Tests to Reduce Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Low- and Middle-Income Countries: A Mathematical Modelling Study Applied to Zambia Han, Alvin X Girdwood, Sarah J Khan, Shaukat Sacks, Jilian A Toporowski, Amy Huq, Naushin Hannay, Emma Russell, Colin A Nichols, Brooke E Clin Infect Dis Major Article BACKGROUND: Increasing the availability of antigen rapid diagnostic tests (Ag-RDTs) in low- and middle-income countries (LMICs) is key to alleviating global SARS-CoV-2 testing inequity (median testing rate in December 2021–March 2022 when the Omicron variant was spreading in multiple countries: high-income countries = 600 tests/100 000 people/day; LMICs = 14 tests/100 000 people/day). However, target testing levels and effectiveness of asymptomatic community screening to impact SARS-CoV-2 transmission in LMICs are unclear. METHODS: We used Propelling Action for Testing and Treating (PATAT), an LMIC-focused agent-based model to simulate coronavirus disease 2019 (COVID-19) epidemics, varying the amount of Ag-RDTs available for symptomatic testing at healthcare facilities and asymptomatic community testing in different social settings. We assumed that testing was a function of access to healthcare facilities and availability of Ag-RDTs. We explicitly modelled symptomatic testing demand from individuals without SARS-CoV-2 and measured impact based on the number of infections averted due to test-and-isolate. RESULTS: Testing symptomatic individuals yields greater benefits than any asymptomatic community testing strategy until most symptomatic individuals who sought testing have been tested. Meeting symptomatic testing demand likely requires at least 200–400 tests/100 000 people/day, on average, as symptomatic testing demand is highly influenced by individuals without SARS-CoV-2. After symptomatic testing demand is satisfied, excess tests to proactively screen for asymptomatic infections among household members yield the largest additional infections averted. CONCLUSIONS: Testing strategies aimed at reducing transmission should prioritize symptomatic testing and incentivizing test-positive individuals to adhere to isolation to maximize effectiveness. Oxford University Press 2022-10-08 /pmc/articles/PMC9619661/ /pubmed/36208211 http://dx.doi.org/10.1093/cid/ciac814 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Major Article
Han, Alvin X
Girdwood, Sarah J
Khan, Shaukat
Sacks, Jilian A
Toporowski, Amy
Huq, Naushin
Hannay, Emma
Russell, Colin A
Nichols, Brooke E
Strategies for Using Antigen Rapid Diagnostic Tests to Reduce Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Low- and Middle-Income Countries: A Mathematical Modelling Study Applied to Zambia
title Strategies for Using Antigen Rapid Diagnostic Tests to Reduce Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Low- and Middle-Income Countries: A Mathematical Modelling Study Applied to Zambia
title_full Strategies for Using Antigen Rapid Diagnostic Tests to Reduce Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Low- and Middle-Income Countries: A Mathematical Modelling Study Applied to Zambia
title_fullStr Strategies for Using Antigen Rapid Diagnostic Tests to Reduce Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Low- and Middle-Income Countries: A Mathematical Modelling Study Applied to Zambia
title_full_unstemmed Strategies for Using Antigen Rapid Diagnostic Tests to Reduce Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Low- and Middle-Income Countries: A Mathematical Modelling Study Applied to Zambia
title_short Strategies for Using Antigen Rapid Diagnostic Tests to Reduce Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Low- and Middle-Income Countries: A Mathematical Modelling Study Applied to Zambia
title_sort strategies for using antigen rapid diagnostic tests to reduce transmission of severe acute respiratory syndrome coronavirus 2 in low- and middle-income countries: a mathematical modelling study applied to zambia
topic Major Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619661/
https://www.ncbi.nlm.nih.gov/pubmed/36208211
http://dx.doi.org/10.1093/cid/ciac814
work_keys_str_mv AT hanalvinx strategiesforusingantigenrapiddiagnosticteststoreducetransmissionofsevereacuterespiratorysyndromecoronavirus2inlowandmiddleincomecountriesamathematicalmodellingstudyappliedtozambia
AT girdwoodsarahj strategiesforusingantigenrapiddiagnosticteststoreducetransmissionofsevereacuterespiratorysyndromecoronavirus2inlowandmiddleincomecountriesamathematicalmodellingstudyappliedtozambia
AT khanshaukat strategiesforusingantigenrapiddiagnosticteststoreducetransmissionofsevereacuterespiratorysyndromecoronavirus2inlowandmiddleincomecountriesamathematicalmodellingstudyappliedtozambia
AT sacksjiliana strategiesforusingantigenrapiddiagnosticteststoreducetransmissionofsevereacuterespiratorysyndromecoronavirus2inlowandmiddleincomecountriesamathematicalmodellingstudyappliedtozambia
AT toporowskiamy strategiesforusingantigenrapiddiagnosticteststoreducetransmissionofsevereacuterespiratorysyndromecoronavirus2inlowandmiddleincomecountriesamathematicalmodellingstudyappliedtozambia
AT huqnaushin strategiesforusingantigenrapiddiagnosticteststoreducetransmissionofsevereacuterespiratorysyndromecoronavirus2inlowandmiddleincomecountriesamathematicalmodellingstudyappliedtozambia
AT hannayemma strategiesforusingantigenrapiddiagnosticteststoreducetransmissionofsevereacuterespiratorysyndromecoronavirus2inlowandmiddleincomecountriesamathematicalmodellingstudyappliedtozambia
AT russellcolina strategiesforusingantigenrapiddiagnosticteststoreducetransmissionofsevereacuterespiratorysyndromecoronavirus2inlowandmiddleincomecountriesamathematicalmodellingstudyappliedtozambia
AT nicholsbrookee strategiesforusingantigenrapiddiagnosticteststoreducetransmissionofsevereacuterespiratorysyndromecoronavirus2inlowandmiddleincomecountriesamathematicalmodellingstudyappliedtozambia